Morning Overview on MSN
Can humans survive rabies? What we know about rare cases
Rabies kills virtually every person who develops symptoms, yet a small number of patients have defied that near-absolute fatality rate. Across the medical literature, about 34 well-documented ...
Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.
Alongside R1 Therapeutics, Mestag Therapeutics and iDEL Therapeutics also brought in money on Tuesday, helping to push their respective cancer portfolios forward.
Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 million, with enhanced financial flexibility following success ...
Zacks Small Cap Research on MSN
PLX: 2025 full year results
By John Vandermosten, CFA NYSE: PLX READ THE FULL PLX RESEARCH REPORT 2025 Financial and Operational Review Protalix BioTherapeutics, Inc. (NYSE: PLX) announced 2025 financial and operational results ...
Patients grappling with unexplained nerve disorders may finally have a clearer and more affordable route to diagnosis, with AIIMS New Delhi rolling out specialised blood tests tha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results